APTX Apotex Health Corp.

29.15USD41.70 CAD · TSX+1.29%Mkt Cap: 6.68B USDP/E: —

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a portfolio of prescription and generic pharmace…

Institutional holders10 on file

Key Statistics

Company
Market Cap6.68B USD
Enterprise Value8.68B USD
Revenue (TTM)2.24B USD
Gross Profit1.36B USD
Net Income (TTM)261.29M USD
Revenue/Share10.99 USD
Last Price29.15 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees6.0K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA03772D1015
Valuation
P/E (Trailing)—
P/E (Forward)17.57
PEG—
EV/EBITDA16.18
EV/Revenue3.87
P/S2.98
P/B22.13
EPS (TTM)-0.02 USD
EPS (Forward)1.66 USD
52W Range
18.2196% of range29.58
52W High29.58 USD
52W Low18.21 USD
Profitability
Gross Margin55.62%
Oper. Margin19.42%
EBITDA Margin23.93%
Profit Margin10.71%
ROE-66.99%
ROA8.23%
ROIC25.71%
ROCE33.56%
Growth
Revenue Growth1.10%
Earnings Growth-4.50%
Cash Flow & Leverage
Operating CF448.06M USD
CapEx (TTM)127.21M USD
FCF Margin—
FCF Yield—
Net Debt2.00B USD
Net Debt/EBITDA3.73
Net Debt/FCF—
Balance Sheet
Debt/Equity-6.31
Current Ratio1.76
Quick Ratio0.83
Book Value/Sh1.32 USD
Cash/Share0.24 USD
Dividends
Fwd Div Rate0.04 USD
Trail. Div Rate0.04 USD
Div. Yield0.15%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 14, 2026
Pay DateSep 30, 2026
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.85 USD
Upside (mean)+5.8%
Target Range27.96 USD – 33.55 USD
27.96+5.8% to mean33.55
# Analysts14
Ownership
Shares Out.229.03M
Float228.72M
Insiders14.34%
Institutions58.00%
Short Interest
Short Ratio4.7d
Short % Out.0.59%
Shares Short1.36M
Short (prev mo.)1.53M
Technical
SMA 5023.49 (+24.1%)
SMA 20023.71 (+22.9%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)384.86K
Avg Vol (10d)551.08K
Technical Indicators
RSI (14)81.9
MACD2.1724
MACD Signal1.4498
MACD Hist.+0.7226
BB Upper29.47 USD
BB Middle24.99 USD
BB Lower20.51 USD
BB Width35.82%
ATR (14)0.8159 USD
Vol Ratio (20d)1.83x

About Apotex Health (TSE: APTX)

›

Apotex Health (TSE: APTX) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 6,000 employees.

The shares were at 41.70 CAD on 19 November 2026. Its 52-week range is 26.05 CAD to 42.31 CAD: the price is 1.4% below the high and 60.1% above the low.

Its market capitalisation is 9.55B CAD. It pays a dividend yielding 0.15%, against a median of 1.90% among the dividend payers in that peer group.

Apotex Health reports return on equity of -67.0%, an operating margin of 19.4% and revenue up 1.1% year over year.

Its debt exceeds its cash by 2.86B CAD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 44.13 CAD is 5.8% above the current price. The next earnings report is expected on 10 February 2027.